NTR vs. BMY
Compare and contrast key facts about Nutrien Ltd. (NTR) and Bristol-Myers Squibb Company (BMY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NTR or BMY.
Correlation
The correlation between NTR and BMY is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
NTR vs. BMY - Performance Comparison
Key characteristics
NTR:
-0.43
BMY:
0.42
NTR:
-0.45
BMY:
0.85
NTR:
0.95
BMY:
1.10
NTR:
-0.20
BMY:
0.26
NTR:
-0.74
BMY:
1.29
NTR:
15.88%
BMY:
9.71%
NTR:
27.25%
BMY:
30.08%
NTR:
-58.18%
BMY:
-70.62%
NTR:
-53.93%
BMY:
-24.21%
Fundamentals
NTR:
$23.16B
BMY:
$112.52B
NTR:
$1.36
BMY:
-$4.41
NTR:
1.24
BMY:
1.31
NTR:
$20.37B
BMY:
$36.44B
NTR:
$6.23B
BMY:
$23.27B
NTR:
$3.24B
BMY:
$11.69B
Returns By Period
In the year-to-date period, NTR achieves a 7.09% return, which is significantly higher than BMY's -0.08% return.
NTR
7.09%
-6.18%
-2.62%
-12.66%
10.12%
N/A
BMY
-0.08%
-8.50%
4.74%
13.05%
3.15%
1.85%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NTR vs. BMY — Risk-Adjusted Performance Rank
NTR
BMY
NTR vs. BMY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Nutrien Ltd. (NTR) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NTR vs. BMY - Dividend Comparison
NTR's dividend yield for the trailing twelve months is around 4.57%, more than BMY's 4.41% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NTR Nutrien Ltd. | 4.57% | 4.83% | 3.76% | 2.63% | 2.45% | 3.74% | 3.67% | 3.47% | 0.00% | 0.00% | 0.00% | 0.00% |
BMY Bristol-Myers Squibb Company | 4.41% | 4.24% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% | 2.46% |
Drawdowns
NTR vs. BMY - Drawdown Comparison
The maximum NTR drawdown since its inception was -58.18%, smaller than the maximum BMY drawdown of -70.62%. Use the drawdown chart below to compare losses from any high point for NTR and BMY. For additional features, visit the drawdowns tool.
Volatility
NTR vs. BMY - Volatility Comparison
Nutrien Ltd. (NTR) has a higher volatility of 9.53% compared to Bristol-Myers Squibb Company (BMY) at 8.96%. This indicates that NTR's price experiences larger fluctuations and is considered to be riskier than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
NTR vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between Nutrien Ltd. and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities